349 results match your criteria: "Institute for Neurological Research RaĂşl Carrea[Affiliation]"
Mov Disord
May 2024
Movement Disorders, Neurology Department, RaĂşl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
Background: One of the characteristics of parkinsonian tremor is that its amplitude decreases with movement. Current models suggest an interaction between basal ganglia (BG) and cerebello-thalamo-cortical circuits in parkinsonian tremor pathophysiology.
Objective: We aimed to correlate central oscillation in the BG with electromyographic activity during re-emergent tremor in order to detect changes in BG oscillatory activity when tremor is attenuated by movement.
Arch Bronconeumol
August 2023
Intensive Care Unit, RaĂşl Carrea Neurological Research Institute, FLENI, Buenos Aires, Argentina.
Mov Disord Clin Pract
June 2023
Raul Carrea Institute for Neurological Research, Movement Disorders Section Buenos Aires Argentina.
Parkinsonism Relat Disord
February 2023
Movement Disorders Service, Neuroscience Department, Institute for Neurological Research RaĂşl Carrea (FLENI), Buenos Aires, Argentina; National Research Council (CONICET), Buenos Aires, Argentina. Electronic address:
Background: Whether there may be any relationship between stressful or traumatic life events (LE) and the subsequent motor symptoms onset in Parkinson's disease (PD) is still controversial.
Objectives: To explore whether a subjectively perceived as stressful or traumatic LE were more frequently present in a group of recent motor onset parkinsonian patients (Recent Onset Parkinsonism - ROP) compared with healthy controls (HC) and a group of patients already diagnosed as PD.
Methods: A consecutive series of 139 ROP patients, 138 matched PD patients and 138 HC were pooled through a validated LE exposure questionnaire evaluating the number of patients affected by LE and the amount of LE per group occurred in the last year, segregating by subjective severity in total and severe LE.
Neurol India
November 2022
Department of Neurology. Institute for Neurological Research Dr. RaĂşl Carrea, Fleni. Buenos Aires, Argentina.
Int J Mol Sci
September 2022
Centre de Recherche du CHUS, Department of Biochemistry, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
Fragile X Syndrome (FXS) is the most prevalent monogenic cause of Autism Spectrum Disorders (ASDs). Despite a common genetic etiology, the affected individuals display heterogenous metabolic abnormalities including hypocholesterolemia. Although changes in the metabolism of fatty acids (FAs) have been reported in various neuropsychiatric disorders, it has not been explored in humans with FXS.
View Article and Find Full Text PDFAnn Clin Transl Neurol
September 2022
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Objective: To determine the sensitivity and specificity of cutaneous amyloid deposition in relation to patient-reported measures in the earliest disease stage of hereditary ATTR amyloidosis (ATTRv).
Methods: In a cross-sectional study, we analyzed 88 individuals with TTR mutations, 47 of whom were in the earliest disease stage and without clinically evident neuropathy, 12 healthy controls, and 13 disease controls with diabetes. All participants' neuropathy symptoms and signs were assessed using validated patient and clinician-reported measures and 3-mm skin punch biopsies were immunostained using protein gene product 9.
Neuromuscul Disord
July 2022
Neurology Department, Raul Carrea Institute for Neurological Research (FLENI), Montañeses 2325, Buenos Aires 1428, Argentina.
Several cases of Guillain-Barré Syndrome (GBS) associated with COVID-19 vaccination have been reported, including the rare subtype known as Bilateral Facial Palsy with paresthesias (BFP). To date, it is not known whether a causal relationship may exist between the two. We report 9 cases of BFP in patients vaccinated against COVID-19 in the previous month.
View Article and Find Full Text PDFMov Disord
May 2022
The Edmond J. Safra Program in Parkinson's Disease and The Morton and Gloria Shulman Movement Disorder Clinic, Toronto Western Hospital, University of Toronto, Toronto, Canada.
In 2016, the Movement Disorder Society Task Force for the Nomenclature of Genetic Movement Disorders presented a new system for naming genetically determined movement disorders and provided a criterion-based list of confirmed monogenic movement disorders. Since then, a substantial number of novel disease-causing genes have been described, which warrant classification using this system. In addition, with this update, we further refined the system and propose dissolving the imaging-based categories of Primary Familial Brain Calcification and Neurodegeneration with Brain Iron Accumulation and reclassifying these genetic conditions according to their predominant phenotype.
View Article and Find Full Text PDFMult Scler Relat Disord
May 2022
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Laboratory of Brain Imaging, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland. Electronic address:
Background: The "1/3″ brain magnetic resonance imaging (MRI) criteria including 1) a lesion adjacent to the lateral ventricle and in the inferior temporal lobe, or 2) a juxtacortical lesion, or 3) a Dawson finger-type lesion were shown to distinguish multiple sclerosis (MS) from antibody-mediated conditions. In this large multicentre study, we aimed to assess how the criteria perform 1) in different onset phenotypes, 2) distinct ethnic groups, 3) when the absence of myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated disease (MOGAD)-typical fluffy infratentorial (FIT) lesions and longitudinally extensive transverse myelitis (LETM) lesions are added as features ("2/4″ and 3/5″ criteria, respectively).
Methods: 577 patients with MS (n = 332), aquaporin-4 antibody (AQP4-Ab) neuromyelitis optica spectrum disorder (NMOSD) (n = 196) and MOGAD (n = 49) were recruited from 6 international centres (Buenos Aires, Sao Paolo, Maracaibo, Goyang, Oxford and Milan).
Arq Neuropsiquiatr
May 2022
Raul Carrea Institute for Neurological Research, Department of Neuromuscular, Buenos Aires, Argentina.
Background: A treatment-related fluctuation (TRF) in a patient with Guillain-Barré syndrome (GBS) is defined as clinical deterioration within two months of symptom onset following previous stabilization or improvements with treatment.
Objective: To investigate the clinical characteristics and factors that could increase the risk of relapse of GBS in patients with and without TRFs.
Methods: Retrospective review of medical records of patients (>18 years) with GBS evaluated between January/2006 and July/2019.
Brain Pathol
September 2022
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Aims: Resource-strained healthcare ecosystems often struggle with the adoption of the World Health Organization (WHO) recommendations for the classification of central nervous system (CNS) tumors. The generation of robust clinical diagnostic aids and the advancement of simple solutions to inform investment strategies in surgical neuropathology would improve patient care in these settings.
Methods: We used simple information theory calculations on a brain cancer simulation model and real-world data sets to compare contributions of clinical, histologic, immunohistochemical, and molecular information.
Annu Rev Pathol
January 2022
Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; email:
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative disease that affects the central nervous system (CNS). MS is characterized by immune dysregulation, which results in the infiltration of the CNS by immune cells, triggering demyelination, axonal damage, and neurodegeneration. Although the exact causes of MS are not fully understood, genetic and environmental factors are thought to control MS onset and progression.
View Article and Find Full Text PDFImmunology
November 2021
Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Buenos Aires, Argentina.
Multiple sclerosis (MS) is currently thought to arise by interactions between genetic susceptibility and environmental factors. Infections in general trigger autoimmune responses causing clinical manifestations of disease. However, as a result of regulatory T (Treg)- and regulatory B (Breg)-cell induction, helminth infections tend to dampen disease activity.
View Article and Find Full Text PDFArq Neuropsiquiatr
May 2021
Biogen S.R.L., Buenos Aires, Argentina.
Background: The real-world effectiveness of natalizumab in people with relapsing multiple sclerosis (PwRMS) in Argentina and Chile has not been reported.
Objective: To evaluate the effectiveness of natalizumab treatment in PwRMS in Argentina and Chile, in clinical practice.
Methods: We conducted a multicenter retrospective and observational study.
Neurol Sci
April 2021
ClĂnica de Esclerosis MĂşltiple, Hospital Ramos MejĂa, Buenos Aires, Argentina.
Background: Technological advances and greater availability of magnetic resonance imaging have prompted an increment on incidental and unexpected findings within the central nervous system. The concept of radiologically isolated syndrome characterizes a group of subjects with images suggestive of demyelinating disease in the absence of a clinical episode compatible with multiple sclerosis. Since the description of this entity, many questions have arisen; some have received responses but others remain unanswered.
View Article and Find Full Text PDFStress Health
August 2021
Chronobiology Lab, National University of Quilmes (UNQ), Buenos Aires, Argentina.
Working in extreme environments requires a wide range of cognitive, psychological and social competences. Antarctica represents one of the most challenging habitats to work in due to its aridity, extremely cold weather, and isolated conditions. This study aimed to assess mood variations and coping strategies, as well as their possible modulation by group dynamics in a crew at the Belgrano II Argentine Antarctic Station throughout 1 year of confinement.
View Article and Find Full Text PDFMov Disord Clin Pract
October 2020
Edmond J. Safra Program in Parkinson's Disease, Movement Disorders Unit, Neuroscience Department Raul Carrea Institute of Neurological Research, FLENI Buenos Aires Argentina.
Mov Disord
February 2021
Department of Neurology, Faculty of Medicine, P. J. Safarik University, Kosice, Slovak Republic.
Background: We assessed the clinimetric properties of ataxia rating scales and functional tests, and made recommendations regarding their use.
Methods: A systematic literature search was conducted to identify the instruments used to rate ataxia symptoms. The identified rating scales and functional ability tests were reviewed and ranked by the panel as "recommended," "suggested," or "listed" for the assessment of patients with discrete cerebellar disorders, using previously established criteria.
Mov Disord
December 2020
Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Buenos Aires, Argentina.
Background: Multiple sclerosis (MS) is the most common chronic immune-mediated neurological disorder in young adults, more frequently found in women than in men. Therefore, pregnancy-related issues have become an object of concern for MS professionals and patients. The aim of this work was to review the existing data to develop the first Argentine consensus for family planning and pregnancy in MS patients.
View Article and Find Full Text PDFMov Disord Clin Pract
May 2020
Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI Ciudad AutĂłnoma de Buenos Aires Argentina.
Mov Disord Clin Pract
April 2020
GENDA Buenos Aires Argentina.